Clinical Trial Update: Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of atezolizumab as induction therapy in non-small cell lung cancer (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Nonsmall Cell Lung Cancer | Phase 2 | Status: COMPLETED